Sector: Health Care.Industry: Pharmaceuticals
Ikena Oncology Inc is an oncology company. It is focused on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. The company is advancing five clinical, preclinical and discovery programs: IK-007, an EP4 receptor antagonist; IK-175, an AHR antagonist; IK-412, a kynurenine-degrading enzyme Kynase; discovery-stage molecules targeting the Hippo signaling pathway; and a discovery-stage program against an undisclosed target.
Earnings
see more| Q2 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-07-29 | ||||||
| REV | |||||||
| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-21 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IKNA | Ikena Oncology | 1.75% |
Ikena Oncology Company Questions & Answers
Q
How do I buy Ikena Oncology (IKNA) stock?
A
You can purchase shares of Ikena Oncology (NASDAQ: IKNA) through any online brokerage.
Q
Who are Ikena Oncology's (IKNA) main competitors?
A
Other companies in Ikena Oncology’s space includes: Reata Pharmaceuticals (NASDAQ:RETA), Johnson & Johnson (NYSE:JNJ) and Merck & Co (NYSE:MRK).
Q
What is the target price for Ikena Oncology?
A
The latest price target for Ikena Oncology (NASDAQ: IKNA) was reported by Jefferies on 2021-04-20. The analyst firm set a price target for 0.00 expecting IKNA to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
Q
How much is Ikena Oncology (IKNA) stock ?
A
The stock price for Ikena Oncology (NASDAQ: IKNA) is $23.81 last updated Fri May 07 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
Q
When is the next Ikena Oncology (IKNA) dividend?
A
There are no upcoming dividends for Ikena Oncology.
Q
When is Ikena Oncology (NASDAQ:IKNA) reporting earnings?
A
Ikena Oncology’s Q2 earnings are confirmed after-market from now on July 29, 2021.
Q
When is the upcoming split for IKNA?
A
There is no upcoming split for Ikena Oncology.